Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Leonard B. Saltz

1-50 of 349 results

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

scientific article

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

scientific article

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

scientific article published on 8 May 2017

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

scientific article

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

scientific article published on 14 August 2006

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer

scientific article

Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803

scientific article published on 05 July 2006

OncoKB: A Precision Oncology Knowledge Base

scientific article published on 16 May 2017

Hepatic neuroendocrine metastases: does intervention alter outcomes?

scientific article published in April 2000

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.

scientific article published on 22 June 2015

Genomic and biological characterization of exon 4 KRAS mutations in human cancer

scientific article

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

scientific article published on 14 January 2019

Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial

scientific article

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology

scientific article published in March 2017

Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer

scientific article

NCCN Clinical Practice Guidelines in Oncology: colon cancer

scientific article

Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803

scientific article published on 01 August 2007

Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer

scientific article published in August 2007

Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

scientific article published on 09 March 2009

Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study

scientific article published on 17 September 2007

Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803

scientific article published on 6 December 2011

NCCN Clinical Practice Guidelines in Oncology: rectal cancer

scientific article published on 01 September 2009

Developing a cancer-specific geriatric assessment

scientific article published on 01 November 2005

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

scientific article published on 10 May 2010

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

scientific article published on June 2009

Comparative genomic analysis of primary versus metastatic colorectal carcinomas.

scientific article

Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions

scientific article

Primary tumor location as a prognostic factor in metastatic colorectal cancer.

scientific article

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer

scientific article

Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial

scientific article published on 13 January 2014

Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.

scientific article

Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer

scientific article

Potential regional differences for the tolerability profiles of fluoropyrimidines

scientific article published in May 2008

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

scientific article

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption

scientific article published in December 2007

The camptothecins.

scientific article

Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients

scientific article published on 14 January 2015

Neuroendocrine carcinomas of the colon and rectum.

scientific article published on February 2004

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer

scientific article published on 01 March 1996

Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.

scientific article published on September 2008

The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor

scientific article

Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection

scientific article published in March 2004

Neuroendocrine tumors, version 1.2015.

scientific article published in January 2015

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients

scientific article

HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum

scientific article

Colon Cancer, Version 3.2014

scientific article published on July 1, 2014

Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer

scientific article

Extracellular metabolic energetics can promote cancer progression

scientific article

Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials

scientific article published in March 2008

BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer.

scientific article published on 15 April 2014